The value of urine CXCL1 concentration normalized by urine creatinine (CXCL1/Cre) was demonstrated to have great advantage in predicting post-transurethral resection recurrence of bladder cancer patients. This evidence concerns the gene CXCL1 and urinary bladder carcinoma.